ChoA Pharmaceutical Co., LTD. Reports Earnings Results for the Full Year Ended December 31, 2022
March 17, 2023 at 04:28 am EDT
Share
ChoA Pharmaceutical Co., LTD. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was KRW 517.39 million compared to KRW 470.45 million a year ago. Net income was KRW 560.69 million compared to net loss of KRW 8,043.64 million a year ago.
Basic earnings per share from continuing operations was KRW 18 compared to basic loss per share from continuing operations of KRW 260 a year ago. Basic earnings per share was KRW 18 compared to basic loss per share of KRW 260 a year ago.
CHOA PHARMACEUTICAL CO,.LTD is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products are mainly for treatment of indigestion, gastric ulcer, duodenal ulcer, gastritis, gastric hyperacidity, intestinal disorder, constipation, diarrhea, stomachache, calcium deficiency, fatigue, iron deficiency anemia, neurasthenia, hypertension, hyperlipidemia, circulatory disorder, medicine poisoning, hepatic disease, allergic rhinitis, cough, cold, rheumatoid arthritis and others. It also provides nutrition products, health drinks, mixed drinks, beverages for children, cosmetics and others.
CHOA PHARMACEUTICAL CO., LTD. 
